BioSpace News Archive

OncoSec Medical Incorporated today announced that Daniel O’Connor has resigned and that Brian Leuthner , formerly Chief Operating Officer, has been appointed Interim Chief Executive Officer, effective June 25, 2021 .

Endo International plc (NASDAQ: ENDP) will announce its second–quarter 2021 financial results on August 5, 2021 after the U.S. financial markets close and members of its senior management team will host a conference call and webcast on August 6, 2021 at 7:30am ET before the U.S. financial markets open.

Helix BioPharma Corp., an immuno-oncology company developing innovative drug candidates for the prevention and treatment of cancer, announced that it has appointed Marcum LLP as the Company’s new auditor, replacing BDO Canada LLP.

Genentech, a member of the Roche Group (SIX: RO, ROG; OTCQX: RHHBY), announced today that the U.S. Food and Drug Administration (FDA) has issued an Emergency Use Authorization (EUA) for intravenous Actemra®

Alpha Teknova, Inc. (“Teknova”) (Nasdaq: TKNO), a leading provider of critical reagents for the development and production of biopharmaceutical products including drug therapies, novel vaccines, and molecular diagnostics, today announced the pricing of its upsized initial public offering of 6,000,000 shares of its common stock at a price to the public of $16.00 per share

Aerami Therapeutics, Inc. today announced the initiation of dosing in the Phase 1 clinical trial of its drug-device combination product candidate, AER-901, an inhaled imatinib for the treatment of pulmonary arterial hypertension (PAH).

BioVie Inc. today announced that the first patient has been enrolled in the Company’s Phase 2b trial of BIV201 (continuous infusion terlipressin) for the treatment of refractory ascites.

Leonard Award program recognizes innovation and positive achievements in the diabetes community by Eli Lilly and Company.

GT Biopharma, Inc. today announced that GT Biopharma CEO, Tony Cataldo will be presenting as a VIP speaker at the upcoming Sir Anthony Ritossa’s Global Family Office Investment Summit in Monaco from June 30 to July 2, 2021.

ATCC, the world’s premier biological materials management and standards organization, today announced that it’s expanding their collection of next-generation 2-D and 3-D patient tissue-derived in vitro cancer models.